XIGDUO XR 5 mg/1

XIGDUO XR 5 mg/1 combines dapagliflozin and metformin hydrochloride for extended-release blood sugar management. This oral medication supports glucose control in adults with type 2 diabetes. Learn about its uses, effects, and precautions.

XIGDUO XR 5 mg/1 is a combination medication used to improve blood sugar control in adults with type 2 diabetes. It contains dapagliflozin and metformin hydrochloride, which work together to help manage glucose levels. This extended-release tablet is typically taken once daily to support diabetes management.

Common effects of XIGDUO XR 5 mg/1 may include symptoms such as nausea, diarrhea, or headache. Some users may experience urinary tract infections or low blood sugar. Individual responses can vary, and not everyone will experience these effects.

XIGDUO XR 5 mg/1 should be handled with care, especially for those with kidney issues or a history of lactic acidosis. It is important to follow medical advice regarding its use and to monitor blood sugar levels regularly. Always consult a healthcare provider before starting this medication.

XIGDUO XR 5 mg/1 may interact with certain medications, including those that affect kidney function or blood sugar levels. Alcohol and some over-the-counter drugs can also impact its effectiveness. Always inform your healthcare provider about all medications you are taking.